ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,965Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 663

$609K Total Retail Price of All Prescriptions

Rank: 37 out of 663

423 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,435 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 429 391 1 1
LEVOTHYROXINE SODIUM 368 351 2 3
METOPROLOL TARTRATE 263 255 3 11
AMLODIPINE BESYLATE 250 236 4 5
METFORMIN HCL 210 199 5 9
LISINOPRIL 205 192 6 2
HYDROCODONE-ACETAMINOPHEN 191 152 S3 7 6
ATORVASTATIN CALCIUM 191 183 7 13
FUROSEMIDE 174 167 9 7
NAMENDA 158 158 10 57
POTASSIUM CHLORIDE 154 154 11 23
ZOLPIDEM TARTRATE 147 129 12 16
TRIAMTERENE-HCTZ 143 143 13 42
OMEPRAZOLE 133 124 14 4
DONEPEZIL HCL 133 133 14 40
CRESTOR 118 110 16 37
TAMSULOSIN HCL 104 98 17 24
LOSARTAN POTASSIUM 102 95 18 14
TRAMADOL HCL 100 93 19 17
WARFARIN SODIUM 98 96 20 8
CIPROFLOXACIN HCL 98 95 20 74
CITALOPRAM HBR 98 78 20 18
GEMFIBROZIL 88 83 23 109
ADVAIR DISKUS 87 87 24 53
LOVASTATIN 86 86 25 30
OXYBUTYNIN CHLORIDE 80 80 26 99
GABAPENTIN 79 68 27 20
PREDNISONE 78 77 28 39
SYNTHROID 76 75 29 46
FLUTICASONE PROPIONATE 75 74 30 27
CYMBALTA 70 64 31 54
PANTOPRAZOLE SODIUM 69 69 32 45
DOXAZOSIN MESYLATE 66 61 33 73
AZITHROMYCIN 65 61 34 64
DOXYCYCLINE HYCLATE 64 60 35 118
METOPROLOL SUCCINATE 64 64 35 25
HYDROCHLOROTHIAZIDE 61 61 37 12
KLOR-CON M20 59 56 38 70
ALENDRONATE SODIUM 58 44 39 15
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 51 40 138
OXYCODONE-ACETAMINOPHEN 52 52 S2 41 26
CELEBREX 50 50 42 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.